NLRP3 and diabetes mellitus: As subjects with upregulated WAT‐surface expression of LDLR and CD36 have upregulated WAT NLRP3 inflammasome, our findings may explain why human conditions with inherited or induced upregulation of LDLR pathway are linked to higher risk of diabetes.